Rare epidermal growth factor receptor gene alterations in non-small cell lung cancer patients, tyrosine kinase inhibitor response and outcome analysis-Reference-Cited by-同舟云学术

Rare epidermal growth factor receptor gene alterations in non-small cell lung cancer patients, tyrosine kinase inhibitor response and outcome analysis

Published:2021 Issue: Volume:28 Page:100398
ISSN:2468-2942
Container-title:Cancer Treatment and Research Communications
language:en
Short-container-title:Cancer Treatment and Research Communications

Author:

Mehta Anurag,Vasudevan Smreti

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Predictive biomarkers in nonsmall cell carcinoma and their clinico-pathological association;Mehta;South Asian J. Cancer,2019

2. Screening for EGFR mutations in lung cancer, a report from India;Sahoo;Lung Cancer,2011

3. Prognostic value of EGFR 19-del and 21-L858R mutations in patients with non-small cell lung cancer;Hong;Oncol. Lett.,2019

4. Clinical outcomes of EGFR-TKI treatment and genetic heterogeneity in lung adenocarcinoma patients with EGFR mutations on exons 19 and 21;Yu;Chin. J. Cancer,2016

5. Uncommon EGFR Mutations. www.uncommonegfrmutations.com. Boehringer Ingelheim International GmbH. Last accessed on 26th March 2021.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The frequency of EGFR gene mutations in a cohort of Romanian patients with non-small cell lung cancer and their association with PD-L1 expression level and ALK rearrangements;Revista Romana de Medicina de Laborator;2024-07-01

2. Uncommon and Rare EGFR Mutations in Non-Small Cell Lung Cancer Patients with a Focus on Exon 20 Insertions and the Phase 3 PAPILLON Trial: The State of the Art;Cancers;2024-03-29

3. Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need;International Journal of Molecular Sciences;2023-05-17

4. Non‐small cell lung cancer with EGFR ( L858R and E709X ) and CNNB1 mutations responded to afatinib;Thoracic Cancer;2022-12-15

5. A pulmonary enteric adenocarcinoma patient harboring a rare EGFR exon 19 P753S mutation: Case report and review;Frontiers in Oncology;2022-09-23